By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Quintiles and London Genetics have struck a partnership to provide biomarker and pharmacogenomics consulting and services to biopharmaceutical firms, Research Triangle Park, NC-based Quintiles said today.

The two companies will collaborate to provide pharmacogenetic solutions, including novel biomarker and assay development services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.